Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
2001 · Clinical Chemistry · 785 citations
https://doi.org/10.1093/clinchem/47.4.624
M
Michael J. Duffy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
352
Papers
26.5K
Citations
85
h-index
200
i10-index
Michael J. Duffy is an academic researcher from North Carolina State University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Protease and Inhibitor Mechanisms & Estrogen and related hormone effects. The author has an h-index of 85, co-authored 300 publications.
ORCID: 0000-0002-9259-6619Papers by this author
worksMetalloproteinases: role in breast carcinogenesis, invasion and metastasis
2000 · Breast Cancer Research · 628 citations
https://doi.org/10.1186/bcr65
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017 · European Journal of Cancer · 518 citations
https://doi.org/10.1016/j.ejca.2017.01.017
Mutant p53 as a target for cancer treatment
2017 · European Journal of Cancer · 363 citations
https://doi.org/10.1016/j.ejca.2017.06.023
Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
2010 · Molecular Cancer Therapeutics · 336 citations
https://doi.org/10.1158/1535-7163.mct-09-1171
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
2014 · Breast Cancer Research · 263 citations
https://doi.org/10.1186/s13058-014-0428-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat